Pharma-Bio Serv, Inc.
PBSV
$0.51
-$0.09-15.00%
OTC PK
| 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.42M | 2.47M | 2.33M | 2.42M | 2.38M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.42M | 2.47M | 2.33M | 2.42M | 2.38M |
| Cost of Revenue | 1.60M | 1.70M | 1.61M | 1.78M | 1.76M |
| Gross Profit | 818.70K | 768.10K | 726.60K | 635.40K | 618.50K |
| SG&A Expenses | 917.00K | 860.30K | 880.70K | 1.02M | 931.90K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.52M | 2.56M | 2.49M | 2.80M | 2.69M |
| Operating Income | -98.30K | -92.20K | -154.10K | -381.80K | -313.40K |
| Income Before Tax | 100.90K | 9.70K | -14.80K | -290.20K | -192.60K |
| Income Tax Expenses | 5.50K | 1.10K | -31.00K | 19.00K | 21.20K |
| Earnings from Continuing Operations | 95.40K | 8.50K | 16.10K | -309.20K | -213.80K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 95.40K | 8.50K | 16.10K | -309.20K | -213.80K |
| EBIT | -98.30K | -92.20K | -154.10K | -381.80K | -313.40K |
| EBITDA | -79.50K | -82.80K | -148.20K | -377.20K | -307.90K |
| EPS Basic | 0.00 | 0.00 | 0.00 | -0.01 | -0.01 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | -0.01 | -0.01 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | -0.01 | -0.01 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 22.93M | 22.96M | 22.97M | 22.96M | 22.96M |
| Average Diluted Shares Outstanding | 22.94M | 22.96M | 22.97M | 22.96M | 22.97M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 1,803.74% | -- | 0.00% | -- | -805.47% |